SPXA Financials 07/16/2014 20:14:59 SpectrumDNA,
Post# of 4
Posted On: 07/16/2014 9:14:55 PM
SPXA Financials 07/16/2014 20:14:59
SpectrumDNA, Inc.
Period Ending Dec 31, 2010
Total Revenue 141
Cost of Revenue 4
Gross Profit 137
Operating Expenses
Research and Development 85
Sales, General and Admin. 1,943
Non-Recurring Items 25
Other 8
Operating Income (1,924)
Income From Continuing Operations
Add'l Income/Expense Items 8
Earnings Before Interest and Tax (1,916)
Interest Expense 51
Earnings Before Tax (1,967)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (1,967)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (1,967)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (1,967)
SpectrumDNA, Inc.
Period Ending Dec 31, 2010
Total Revenue 141
Cost of Revenue 4
Gross Profit 137
Operating Expenses
Research and Development 85
Sales, General and Admin. 1,943
Non-Recurring Items 25
Other 8
Operating Income (1,924)
Income From Continuing Operations
Add'l Income/Expense Items 8
Earnings Before Interest and Tax (1,916)
Interest Expense 51
Earnings Before Tax (1,967)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (1,967)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (1,967)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (1,967)
(0)
(0)Spectrumdna Inc (SPXA) Stock Research Links
Scroll down for more posts ▼